Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials
Alzheimer’s disease is a multifactorial progressive neurodegenerative disorder characterized by memory loss, disorientation, and gradual decline in intellectual ability. The accumulation of beta-amyloid (Aβ) peptides is assessed to be one of the essential neuropathological pillars of the disorder, and its dishomeostasis plays an essential
Young Children with Obsessive Compulsive Disorder
Juvenile obsessive-compulsive disorder (OCD) often starts at the mean age of 10.3 years. However, OCD manifests at even younger age in some patients. An earlier age of onset and a longer duration of illness have been associated with increased persistence of OCD. Objective To understand the clinical presentation, diagnosis and possible treatment of OCD in […]